Peripheral and Central Nervous System Drugs Advisory Committee; Cancellation

---
identifier: "/us/fr/03-10150"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Peripheral and Central Nervous System Drugs Advisory Committee; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "03-10150"
section_name: "Peripheral and Central Nervous System Drugs Advisory Committee; Cancellation"
positive_law: false
currency: "2003-04-24"
last_updated: "2003-04-24"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-10150"
document_type: "notice"
publication_date: "2003-04-24"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "68 FR 20158"
fr_volume: 68
fr_action: "Notice."
---


#  Peripheral and Central Nervous System Drugs Advisory Committee; Cancellation

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is cancelling the meeting of the Peripheral and Central Nervous System Drugs Advisory Committee scheduled for May 16, 2003. This meeting was announced in the *Federal Register* of April 14, 2003 (68 FR 17958).

**FOR FURTHER INFORMATION CONTACT:**

Karen M. Templeton-Somers, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area) code 12543, or e-mail: *[email protected]* .

Dated:  April 18, 2003.

Lester M. Crawford,

Deputy Commissioner.